Essential fatty acids and sleep: Mini-review and hypothesis

Medical Hypotheses

Volumn 50, Issue 2, 1998, Pages 139-145

  Yehuda, S ^a   Rabinovitz, S ^a   Mostofsky, D I ^b  

^a BAR ILAN UNIVERSITY   (Israel)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ESSENTIAL FATTY ACID; INTERLEUKIN DERIVATIVE; LIPID; NEUROTRANSMITTER; PROSTAGLANDIN;

BLOOD BRAIN BARRIER; FATTY ACID METABOLISM; GLUCOSE TRANSPORT; HUMAN; NERVE CELL MEMBRANE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SLEEP;

EID: 0031933352     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90200-6     Document Type: Article

References (72)

1. Yehuda S, Rabinovitz S, Mostofsky D I. Effects of essential fatty acid preparation (SR-3) on brain lipids, biochemistry and behavioral and cognitive functions. In: Yehuda S, Mostofsky D I, eds. Handbook of Fatty Acid Biology: Biochemistry, Physiology and Behavioral Neurobiology. Totowa, NJ: Humana Press, 1997.
2. Coscina D V, Yehuda S, Kish S J, Leprohon-Greenwood C E. Learning is improved by soybean oil diet in rats. Life Sci 1986; 38: 1789-1794.
3. Yehuda S. Behavioral effect of dietary fats. In Chandra R K, ed. Health Effects of Fish and Fish Oils. St John's, Newfoundland: Arts Biomedical Publications, 1989: 327-335.
4. Yehuda S, Carasso R L. Effects of dietary fats on learning, pain threshold, thermoregulation, and motor activity in rats: interaction with the length of the feeding period. Int J Neurosci 1987; 32: 919-925.
5. Yehuda S, Leprohon-Greenwood C E, Dixon L M, Coscina D V. Effects of dietary fat on pain threshold, thermoregulation and motor activity in rats. Pharm Biochem Behav 1986; 24: 1775-1777.
6. Yehuda S, Carasso R L. Effects of dietary fats on learning, pain threshold, thermoregulation and motor activity in rats: interaction with the length of feeding periods. Int J Neurosci 1987; 32: 919-925.
7. Yehuda S, Carasso R L. Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified α-linolenic and linoleic acids: determination of optimal n-3 to n-6 ratio. Proc Natl Acad Sci USA 1993; 90: 10345-10349.
8. Yehuda S, Carasso R L, Mostofsky D I. Essential fatty acid preparation (SR-3) raises the seizure threshold in rats. Eur J Pharmacol 1994; 254: 193-198.
9. Yehuda S, Carasso R L, Mostofsky D I. Essential fatty acid preparation (SR-3) rehabilitates learning deficits induced by AF64A and 5,7-DHT. Neuroreport 1995; 6: 511-515.
10. Yehuda S, Brandys Y, Blumenfeld A, Mostofsky D I. Essential fatty acid preparation reduces cholesterol and fatty acids in rat cortex. Int J Neurosci 1996; 86: 249-256.
11. Pardridge MW. New directions in BBB research. Ann NY Acad Sci 1988; 529: 50-60.
12. Dhopeshwarker G A. Nutrition and brain development. New York: Plenum, 1983.
13. Narial T, DeGeorge J J, Greig N H, Genka S, Rapoport S I, Purdon A D. Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats. Clin Expt Metastasis 1994; 12: 213-225.
14. Spector R. Fatty acid transport through the blood-brain barrier. J Biochem 1988; 60: 639-643.
15. Avellini L, Terracina L, Gaiti A. Linoleic acid passage through the blood-brain barrier and a possible effect of age. Neurochem Res 1994; 19: 129-133.
16. Moore S A, Yoder E, Spector A A. Role of the blood-brain barrier in the formation of long-change omega-3 and omega-6 fatty acids from essential fatty acid precursors. J Neurochem 1990; 55: 391-402.
17. +)-ATPase. J Neurochem 1988; 50: 1215-1219.
18. Dhillon H S, Donaldson D, Dempsey R J, Prasad M R. Regional levels of free fatty acids and Evans blue extravasation after experimental brain injury. J Neurotrauma 1994; 11: 405-415.
19. Shi F, Cavitt J, Audus K L. 21-aminosteroid and 2-(aminomethyl) chromans inhibition of arachidonic acid-induced lipid peroxidation and permeability enhancement in bovine brain microvessel endothelial cell monolayers. Free Radical Biol Med 1995; 19: 349-357.
20. Hussain S T, Roots B I. Effects of essential fatty acid deficiency and immunopathological stresses on blood-brain barrier (B-BB) in Lewis rats: a biochemical study. Biochemical Soc Trans 1994; 2: 338S.
21. Mooradian A D, Smith T L. The effect of experimentally induced diabetes mellitus on the lipid order and composition of rat cerebral microvessels. Neurosci Lett 1992; 145: 145-148.
22. Ziylan Z Y, Bernard G C, Lefauconnier J M, Durand G A, Bourre JM. Effect of dietary n-3 fatty acid deficiency on blood-to-brain transfer of sucrose, alpha-aminosobutyric acid and phenylalanine in the rat. Neurosci Lett 1992; 137: 9-13.
23. Pouliot J F, Beliveau R. Palmitoylation of the glucose transporter in blood-brain barrier capillaries. Biochem Biophys Acta 1995; 1234: 191-196.
24. Stein D T, Esser V, Stevenson B E et al. Essential secretion of circulating fatty acids for glucose-stimulated insulin in the fasted rat. J Clin Invest 1996; 97: 2728-2735.
25. Harris W S. n-3 fatty acids and lipoproteine: comparison of results from human and animal studies. Lipids 1996; 243-252.
26. Frank S A, Roland D C, Sturis J et al. Effects of medicine, University of Chicago, Illinois 60637, USA. Am J Physiol 1995; 269: 1006-1016.
27. Arankowsky-Sandoval G, Gold P E. Morphine-induced deficits in sleep patterns: attenuation by glucose. Neurobiol Learn Mem 1995; 64: 133-138.
28. de Saint Hilaire Z, Charnay Y, Mikolajewski R, Gaillard J M. Active immunization against insulin affects sleep and feeding in rats. Physiol Behav 1995; 57: 803-806.
29. + channels by directly binding to the channel proteins. Proc Natl Acad Sci USA 1996; 93: 3542-3546.
30. Fagioli I, Baroncini P, Ricour C, Salzarulo P. Decrease of slow wave sleep in children with prolonged absence of essential lipids intake. Sleep 1989; 12: 495-499.
31. Schroeder F, Colles S M, Kreishman G P, Heyliger C E, Wood W G. Synaptic plasma membrane structure and polarity of long-sleep and short-sleep mice. Arch Biochem Biophys 1994; 309: 369-376.
32. Erwin V G, Radcliffe R A. Characterization of neurotensin-stimulated phosphoinositide hydrolysis in brain regions of long sleep and short sleep mice. Brain Res 1993; 629: 50-66.
33. Malikova N A, Krzhechkovskaia V V, Marokko I N, Mazo V K. The effect of fatty compounds with different ratios of the polyunsaturated fatty acids of the omega-3 and omega-6 families on the expression of food-related anaphylaxis, on the liver cytochrome p-450 system and on 17-hydroxycorticosteroid metabolism in guinea pigs. Vopr Pitan 1995; 4: 13-16.
34. Cravatt B F, Lerner R A, Boger D L. Structure determination of an endogenous sleep-inducing lipid, cis-9-octadecenamide (oleamide): a synthetic approach to the chemical analysis of trace quantities of a natural product. J Am Chem Soc 1996; 118: 580.
35. Maurelli S, Bisogno T, De Petrocellis L, Di Luccia A, Marino G, Di Marzo V. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma anandaminde amidohydrolase. FEBS Lett 1995; 377: 82-86.
36. Boger D L, Lerner R A. Chemical characterization of a family of brain lipids that induce sleep. Science 1995; 268: 1506-1509.
37. Cravatt B F, Prospero-Garcia O, Suizdak G et al. Chemical characterization of a family of brain lipids that induce sleep. Science 1995; 268: 1506-1509.
38. Lerner R A, Suizdak G, Prospero-Garcia O et al. Cerebrodiene: a brain lipid isolated from sleep-deprived cats. Proc Natl Acad Sci USA 1994; 91: 9505-9508.
39. Cady A B, Kotani S, Shiba T, Kusumoto S, Krueger J M. Somnogenic activities of synthetic lipid A. Infect Immun 1989; 57: 396-403.
40. Hayaishi O, Matsumura H, Urade Y. Prostaglandin D synthase is the key enzyme in the promotion of physiological sleep. J Lipid Mediat 1993; 6: 429-431.
41. Sri Kantha S, Matsumura H, Kubo E et al. Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostaglandins Leukot Essent Fatty Acids 1994; 51: 87-93.
42. Satoh S, Matsumura H, Nakajima T et al. Promotion of sleep by prostaglandin D2 in rats made insomniac by pretreatment with para-chlorophenylalanine. Neurosci Res 1994; 21: 41-50.
43. Kuiper J, Zijlstra F J, Kamps J A, van Berkel T J. Identification of prostaglandin D2 as the major eicosanoid from liver endothelial and Kupffer cells. Biochem Biophys Acta 1988; 959: 143-152.
44. Pandey H P, Ram A, Matsumura H, Satoh S, Hataishi O. Circadian variations of prostaglandin D2, E2 and F2 alpha in the cerebrospinal fluid of anesthetized rats. Biochem Biophys Res Commun 1995; 213: 625-629.
45. Takahata R, Matsumura H, Kantha S S et al. Intravenous administration of inorganic selenium compounds, inhibitors of prostaglandin D synthase, inhibits sleep in freely moving rats. Brain Res 1993; 623: 65-71.
46. Murphy P J, Badia P, Myers B L, Boecker M R, Wright K P Jr. Nonsteriodal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav 1994; 55: 1063-1066.
47. Matsumura H, Honda K, Goh Y, Ueno R et al. Awaking effect of prostaglandin E2 in freely moving rats. Brain Res 1989; 481: 242-249.
48. Schlicker E, Fink K, Gothert M. Influence of eicosanoids on serotonin release in the rat brain: inhibition by prostaglandin El and E2. Naunyn Schmiedebergs Arch Pharmacol 1987; 335: 646-651.
49. Yehuda S, Carasso R L. DSIP - a tool for investigating the sleep onset mechanism: a review. Int J Neurosci 1988; 38: 345-353.
50. Yukhananov R Y, Tennila T M, Miroshnicenko T I et al. Ethanol and delta-sleep-inducing peptide: effects on brain monoamines. Pharmacol Biochem Behav 1992; 43: 683-687.
51. Quichou A, Zitouni M, Raynaud F, Simonneaux V, Gharib A, Pevet P. Delta-sleep-inducing peptide stimulates melatonin, 5-methoxytryptophol and serotonin secretion from perifused rat pineal glands. Biol Signals 1992; 2: 65-77.
52. Kudo M, Kudo T, Matsuki A. Prostaglandin D2-endogenous regulator of physiological sleep-inhibited CRF-induced ACTH secretion from rat anterior pituitary cells. Nippon Naibunpi Gakkai Zasshi 1990; 66: 1158-1163.
53. Edvinsson L, Minthon L, Ekman R, Gustafson L. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration. Dementia 1993; 4: 167-171.
54. Heilig M, Sjogren M, Blennow K, Ekman R, Wallin A. Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia. Biol Psychiatry 1995; 38: 210-216.
55. Wikkelso C, Ekman R, Westergren I, Johansson B. Neuropeptides in cerebrospinal fluid in normal-pressure hydrocephalus and dementia. Eur Neurol 1991; 31: 88-93.
56. Dinarello C, Savage A. Interleukin-1 and its receptor. Crit Rev Immunol 1989; 9: 1-20.
57. Obal F Jr, Opp M, Cady A B et al. Interleukin 1 alpha and an interleukin 1 beta fragment are somnogenic. Am J Physiol 1990; 259: 439-446.
58. Meydani S N. Effect of (n-3) polyunsaturated fatty acids on cytokine production and their biologic function. Suppl Nutr 1996; 12: 8-14.
59. Wu D, Meydani S N, Meydani M, Hayek M G, Huth P, Nicolosi R J. Immunologic effects of marine- and plantderived n-3 polyunsaturated fatty acids in nonhuman primates. Am J Clin Nutr 1996; 63: 273-280.
60. Calder PC. Can n-3 polyunsaturated fatty acids be used as immunomodulatory agents? Biochem Soc Trans 1995; 24: 211-220.
61. Hughes D A, Southon S, Pinder A C. (n-3) polyunsaturated fatty acids modulate the expression of functionally associated molecules on human monocytes in vitro. J Nutr 1996; 126: 603-610.
62. Alexander J W. Specific nutrients and the immune response. Nutrition 1995; 11: 229-232.
63. Aune T M, Golden H W, Mcgrath K M. Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 1994; 153: 489-498.
64. Hellstrand K, Hermodsson S. Serotonergic 5-HT1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes. Scand J Immunol 1993; 37: 7-18.
65. Wilcox B D, Dumin J A, Jeffery J J. Serotonin regulation of interleukin-1 messenger RNA in rat uterine smooth muscle cells: relationship to the production of interstitial collagenase. J Biol Chem 1994; 25: 29658-29664.
66. Young M R, Kut J L, Coogan M P, Wright M A, Young M E, Matthews J. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 1993; 80: 395-400.
67. Corrigan F M, Van Rhijn A, Horrobin D F. Essential fatty acids in Alzheimer's disease. Ann NY Acad Sci 1991; 640: 250-252.
68. Nakada T, Kwee I L, Ellis W G. Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease. Neuroreport 1990; 1: 153-155.
69. Farooqui A A, Wells K, Horrocks L A. Breakdown of membrane phospholipids in Alzheimer disease: involvement of excitatory amino receptors. Mol Chem Neuropathol 1995; 25: 155-173.
70. Newman P E. Could diet be one of the casual factors of Alzheimer's disease? Med Hypotheses 1992; 39: 123-126.
71. Hoyer S. Abnormalities of glucose metabolism in Alzheimer's disease. Ann NY Acad Sci 1991; 640: 53-58.
72. Yehuda S, Rabintovitz S, Carasso R L, Mostofsky D I. Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci 1996; 87: 141-149.